Anadys receives U.S. Patent for setrobuvir to treat chronic hepatitis C Anadys Pharmaceuticals, Inc common sexual disorder . today announced issuance of the U.S. Patent covering setrobuvir , the Company’s Direct-Acting Antiviral in Phase IIb development for chronic hepatitis C virus an infection .S. Patent No. 7,939,524, granted to Anadys by the United States Trademark and Patent Office, recognizes the business’s intellectual property privileges to the composition of matter and ways of use for setrobuvir and related compounds.S. Patent security is a critical step that significantly enhances the value of setrobuvir, said Steve Worland, Ph.D., President and CEO of Anadys. ..
An interactive computer system can help educate women about breasts malignancy risk and genetic testing An interactive computer program can help educate women about breasts cancer risk and genetic screening, and a decision panel offering info on treatment options might help breast cancer sufferers choose between mastectomy and breast-conserving therapy, according to content in the July 28 problem of JAMA, the Journal of the American Medical Association. In the first of two research, Michael J. Green, M.D., M.S., of Penn State College of Medication, Hershey, Pa., and co-workers compared the effectiveness of an interactive, multimedia CD ROM-based decision help with standard genetic counseling for educating women approximately BRCA1 and BRCA2 genetic testing.